DiaSorin stock holds firm as analysts keep nudging forecasts

DiaSorin (IT0003497168) held at EUR 74.94 on Tradegate at 4:02:44 p.m. EDT on August 21, 2026, while the quote showed a 0.35% daily gain and an 8.70% rise since the start of the year.

The latest revisions page for DiaSorin lists the company at 74.94 EUR and places the stock in a year-to-date advance of 8.70%, a useful contrast with the FTSE MIB index where DiaSorin is still down 6.61% over the trailing year on Borsa Italiana's yearly performance table.

Forecast revisions

Analyst estimates remain the main near-term signal in the current data set, and the revisions snapshot shows a one-month revenue revision line, a one-year revenue revision line and a one-year EPS revision line for DiaSorin. That matters because the stock is trading close to the same level as the latest consensus snapshot, which leaves sentiment, not only price action, as the immediate watch point.

The revisions page also places DiaSorin within medical equipment, supplies and distribution, which helps frame the stock's movement against the sector backdrop rather than as a purely idiosyncratic move.

Index backdrop

DiaSorin's place in the FTSE MIB keeps the stock tied to Italy's large-cap benchmark, and the yearly performance table gives a clear historical comparison: 64.00 versus 68.53183 a year earlier, or -6.61%. The same table shows the broader index context that investors often use to compare defensive healthcare names with cyclical leaders.

For the chart, the trade at EUR 74.94 sits above the 64.00 level shown in the benchmark table and well below the kind of broad-market momentum that has lifted several Italian peers this year. The number stands out: 8.70% year-to-date versus a 6.61% year-over-year gap in the FTSE MIB table.

Go deeper

The current product mix still matters because DiaSorin's diagnostics platform spans immunodiagnostics and molecular diagnostics, with assay menus and installed systems driving recurring reagent demand. That business model gives the stock a different profile from drug developers whose valuation can hinge on one pipeline event.

DiaSorin shares close

DiaSorin shares were last quoted at EUR 74.94 on Tradegate on August 21, 2026.

Fact box

Company: DiaSorin S.p.A.
ISIN: IT0003497168
Ticker: DSR
Exchange: Borsa Italiana
Price (as of August 21, 2026, 4:02:44 p.m. EDT): EUR 74.94
Market cap: EUR 8.5 billion
Sector / Industry: Health Care / Medical Equipment, Supplies & Distribution
Index membership: FTSE MIB

More on DiaSorin stock

Investor relations